RxDoctor Payments Data

John Richards, DO

Family Medicine · Charleston, WVNPI 1588627970

Payments from drug & device makers

$4,227in general payments, 2019–2025

Across 277 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$740
  • AbbVie$549
  • GSK$517
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$496
  • AstraZeneca$436
  • Takeda Pharmaceuticals U.S.A., Inc.$311
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$4,227100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,227 in reported general payments places this provider in the 85th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$9,477
Medicare patients
74
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban89$105,347
LinzessLinaclotide24$25,098
XareltoRivaroxaban23$24,961
Combivent RespimatIpratropium/Albuterol Sulfate21$21,775
Soliqua 100-33Insulin Glargine/Lixisenatide25$21,383
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog25$20,226
Breo ElliptaFluticasone/Vilanterol20$18,044
Spiriva HandihalerTiotropium Bromide13$15,810
BrilintaTicagrelor17$15,302
SymbicortBudesonide/Formoterol Fumarate34$13,288
Novolog FlexpenInsulin Aspart29$12,080
JardianceEmpagliflozin13$7,703
Albuterol Sulfate HfaAlbuterol Sulfate91$6,622
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate20$4,220
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$3,741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$740$105,34789 claims
Boehringer IngelheimCombivent Respimat, Jardiance$75$29,47934 claims
AstraZenecaBrilinta, Symbicort$436$28,59051 claims
AbbVieLinzess, Synthroid$549$27,48164 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$247$21,38325 claims
GSKBreo Ellipta$517$18,04420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →